mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-07 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-06 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |